ONCOLYTICS BIOTECH INC (ONC.CA) Stock Analyst Ratings
Canada - TSX:ONC - CA6823108759 - Common Stock
1.42 CAD
+0.03 (+2.16%)
ChartMill assigns a Buy % Consensus number of 78% to ONC.CA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 4.6. This target is 224.02% above the current price.
ONC.CA was analyzed by 8 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about ONC.CA.
In the previous month the buy percentage consensus was at a similar level.
ONC.CA was analyzed by 8 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-06-06 | H.C. WAINWRIGHT & CO., LLC | Maintains | Buy -> Buy |
| 2022-10-06 | Maxim Group | Initiate | Buy |
| 2022-08-22 | RBC Royalbank | Initiate | Outperform |
| 2022-03-07 | HC Wainwright | Initiate | Buy |
| 2021-05-21 | RBC Capital | Reiterate | Outperform |
| 2021-04-13 | RBC Capital | Maintains | Outperform |
ONCOLYTICS BIOTECH INC / ONC.CA FAQ
What is the average price target for ONCOLYTICS BIOTECH INC (ONC.CA) stock?
8 analysts have analysed ONC.CA and the average price target is 4.6 CAD. This implies a price increase of 224.02% is expected in the next year compared to the current price of 1.42.
How do analysts rate ONCOLYTICS BIOTECH INC (ONC.CA)?
The consensus rating for ONCOLYTICS BIOTECH INC (ONC.CA) is 77.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.